TD Cowen 46th Annual Health Care Conference March 2, 2026 9:10 AM ESTCompany ParticipantsChristopher Viehbacher - President, CEO ...
Lilly’s momentum isn’t just about its successful clinical results, though. It’s also about the company’s constant iteration ...
By Leah Douglas WASHINGTON, March 12 (Reuters) - Compounded weight-loss drugs that contain vitamin B12 and the main ingredient in Eli Lilly's Zepbound could present health risks to consumers due to a ...
Eli Lilly (LLY) rated Sell/Avoid: overvaluation, slowing GLP-1 growth, Novo competition, bearish technicals and insider ...
Eli Lilly on Monday launched a new form of its blockbuster obesity drug, Zepbound, that offers a month's worth of doses in a single pen. The pen could serve as a more convenient option for some ...
Bartlett’s Lilly White learned the hard way about letting the outcome define the experience. Last season, White finished outside of the medal round at state. It was a stunning setback, but now as a ...
Federal Reserve policymakers were mostly in agreement on the decision to leave interest rates unchanged despite two calling for cuts, though several signaled that rate hikes could be on deck if ...
Mike Evans is returning for his 13th NFL season, but it might not be with the Tampa Bay Buccaneers. The veteran wide receiver will play in 2026 and plans to explore the free agency market this ...
Novo's drug, CagriSema, didn't achieve its key goal of demonstrating non-inferiority on weight loss when compared to Eli Lilly's rival drug tirzepatide. The stock plummeted on Monday, hitting its ...
The pass rate for the foreign driver's license conversion test in Japan fell to 42.8 percent in the first three months after stricter regulations took effect, down sharply from 92.5 percent in 2024, ...
Add Yahoo as a preferred source to see more of our stories on Google. “This booking wasn’t accidental,” one insider says. “Everyone knows combative 48-year-old Elisabeth’s history with Joy, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results